PERSONAL CFO SOLUTIONS, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
PERSONAL CFO SOLUTIONS, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$111,000
-51.9%
63,165
-11.2%
0.02%
-48.8%
Q4 2021$231,000
-36.2%
71,165
-21.1%
0.04%
-41.9%
Q3 2021$362,000
+182.8%
90,165
+15.4%
0.07%
+184.6%
Q2 2021$128,000
-14.1%
78,1650.0%0.03%
-18.8%
Q1 2021$149,000
-9.7%
78,165
+6.8%
0.03%
-22.0%
Q4 2020$165,00073,165
-17.0%
0.04%
Q3 2020$0
-100.0%
88,165
+17.3%
0.00%
-100.0%
Q2 2020$157,000
+55.4%
75,165
+17.1%
0.05%
+27.8%
Q1 2020$101,00064,1650.04%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders